Show simple item record

Authordc.contributor.authorCastillo, Rodrigo L. 
Authordc.contributor.authorHerrera Videla, Emilio 
Authordc.contributor.authorGonzález Candia, Alejandro 
Authordc.contributor.authorReyes Farías, Marjorie 
Authordc.contributor.authorJara, Nicole de la 
Authordc.contributor.authorPeña, Juan Pedro 
Authordc.contributor.authorCarrasco Pozo, Catalina 
Admission datedc.date.accessioned2018-07-31T15:38:39Z
Available datedc.date.available2018-07-31T15:38:39Z
Publication datedc.date.issued2018
Cita de ítemdc.identifier.citationOxidative Medicine and Cellular Longevity Número de artículo: 7239123es_ES
Identifierdc.identifier.other10.1155/2018/7239123
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/150487
Abstractdc.description.abstractAlterations in cardiac energy metabolism play a key role in the pathogenesis of diabetic cardiomyopathy. Hypercholesterolemia associated with bioenergetic impairment and oxidative stress has not been well characterized in the cardiac function under glycemic control deficiency conditions. This work aimed to determine the cardioprotective effects of quercetin (QUE) against the damage induced by a high-cholesterol (HC) diet in hyperglycemic rats, addressing intracellular antioxidant mechanisms and bioenergetics. Quercetin reduced HC-induced alterations in the lipid profile and glycemia in rats. In addition, QUE attenuated cardiac diastolic dysfunction (increased E:A ratio), prevented cardiac cholesterol accumulation, and reduced the increase in HC-induced myocyte density. Moreover, QUE reduced HC-induced oxidative stress by preventing the decrease in GSH/GSSG ratio, Nrf2 nuclear translocation, HO-1 expression, and antioxidant enzymatic activity. Quercetin also counteracted HC-induced bioenergetic impairment, preventing a reduction in ATP levels and alterations in PGC-1 alpha, UCP2, and PPAR. expression. In conclusion, the mechanisms that support the cardioprotective effect of QUE in rats with HC might be mediated by the upregulation of antioxidant mechanisms and improved bioenergetics on the heart. Targeting bioenergetics with QUE can be used as a pharmacological approach to modulate structural and functional changes of the heart under hypercholesterolemic and hyperglycemic conditions.es_ES
Patrocinadordc.description.sponsorshipFONDECYT 11130232 1151119es_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherHindawi Ltdes_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Sourcedc.sourceOxidative Medicine and Cellular Longevityes_ES
Keywordsdc.subjectInduced endothelial dysfunctiones_ES
Keywordsdc.subjectPancreatic beta-cellses_ES
Keywordsdc.subjectE-knockout micees_ES
Keywordsdc.subjectDiabetic cardiomyopathyes_ES
Keywordsdc.subjectCardiovascular-diseasees_ES
Keywordsdc.subjectUncoupling proteinses_ES
Keywordsdc.subjectHeme oxygenase-1es_ES
Keywordsdc.subjectHeartes_ES
Keywordsdc.subjectHypercholesterolemiaes_ES
Keywordsdc.subjectMitochondriaes_ES
Títulodc.titleQuercetin prevents diastolic dysfunction induced by a high-cholesterol diet: role of oxidative stress and bioenergetics in hyperglycemic ratses_ES
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorrgfes_ES
Indexationuchile.indexArtículo de publicación ISIes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile